Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects

@article{Claes2008CostEA,
  title={Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects},
  author={Christa Claes and R. Reinert and Johann-Matthias Graf von der Schulenburg},
  journal={The European Journal of Health Economics},
  year={2008},
  volume={10},
  pages={25-38}
}
In Germany the heptavalent pneumococcal conjugate vaccine (PCV7) has been recommended as a general infant vaccination since 2006. Data from similar programmes in the USA have reported a reduction of pneumococcal diseases in both vaccinated and unvaccinated populations, suggesting herd immunity effects. This study analyses the cost-effectiveness of a general vaccination with PCV7 in Germany based on these findings. A Markov model adapts efficacy and herd immunity data to the German population… CONTINUE READING